Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Androgens can both increase body hair and cause scalp hair loss.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Androgens can cause hair growth in some areas but hair loss on the scalp.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Uterine transplants for transgender women are feasible but need more research.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.